The 389 patients in the SPOTLIGHT study with recurrent PCa had a median age of 69 y and a median PSA of 1.1 ng/mL, and 79% of those patients had previously undergone radical prostatectomy. The gene discussed is KLK3; the disease is posterior cortical atrophy.